1. Nanoparticles of esterified polymalic acid for controlled anticancer drug release.
- Author
-
Lanz-Landázuri A, Portilla-Arias J, Martínez de Ilarduya A, García-Alvarez M, Holler E, Ljubimova J, and Muñoz-Guerra S
- Subjects
- Cell Line, Tumor, Dacarbazine chemistry, Dacarbazine pharmacokinetics, Dacarbazine pharmacology, Delayed-Action Preparations chemical synthesis, Delayed-Action Preparations chemistry, Delayed-Action Preparations pharmacokinetics, Delayed-Action Preparations pharmacology, Drug Screening Assays, Antitumor, Humans, Nanocapsules ultrastructure, Temozolomide, Antibiotics, Antineoplastic chemistry, Antibiotics, Antineoplastic pharmacokinetics, Antibiotics, Antineoplastic pharmacology, Antineoplastic Agents, Alkylating chemistry, Antineoplastic Agents, Alkylating pharmacokinetics, Antineoplastic Agents, Alkylating pharmacology, Dacarbazine analogs & derivatives, Doxorubicin chemistry, Doxorubicin pharmacokinetics, Doxorubicin pharmacology, Malates chemistry, Malates pharmacokinetics, Malates pharmacology, Nanocapsules chemistry, Polymers chemistry, Polymers pharmacokinetics, Polymers pharmacology
- Abstract
Esterification of microbial poly(malic acid) is performed with either ethanol or 1-butanol to obtain polymalate conjugates capable to form nanoparticles (100-350 nm). Degradation under physiological conditions takes place with release of malic acid and the corresponding alcohol as unique degradation products. The anticancer drugs Temozolomide and Doxorubicin are encapsulated in nanoparticles with efficiency of 17 and 37%, respectively. In vitro drug release assays show that Temozolomide is almost completely discharged in a few hours whereas Doxorubicin is steadily released along several days. Drug-loaded nano-particles show remarkable effectiveness against cancer cells. Partially ethylated poly(malic acid) nano-particles are those showing the highest cellular uptake., (© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.)
- Published
- 2014
- Full Text
- View/download PDF